| Income Statement |
| Operating Expenses | 1.05M |
|
| Research and Development Expense | 174.00K |
| Selling, General and Administrative Expense | 889.00K |
| Operating Income | -1.05M |
| Net Income | -1.12M |
| Net Income Common Stock | -1.12M |
| Net Income Common Stock (USD) | -1.12M |
| Consolidated Income | -1.12M |
| Earnings per Basic Share | -0.18 |
| Earnings per Basic Share (USD) | -0.18 |
| Earnings per Diluted Share | -0.18 |
| Earning Before Interest & Taxes (EBIT) | -1.12M |
| Earning Before Interest & Taxes (USD) | -1.12M |
| Weighted Average Shares | 6.37M |
| Weighted Average Shares Diluted | 6.37M |
| Balance Sheet |
| Cash and Equivalents | 1.72M |
| Cash and Equivalents (USD) | 1.72M |
| Trade and Non-Trade Receivables | 8.00K |
| Current Assets | 2.32M |
| Property, Plant & Equipment Net | 178.00K |
| Total Assets | 11.40M |
| Current Liabilities | 4.17M |
| Total Liabilities | 10.42M |
| Accumulated Retained Earnings (Deficit) | -207.16M |
| Accumulated Other Comprehensive Income | -2.00K |
| Shareholders Equity | 977.00K |
| Shareholders Equity (USD) | 977.00K |
| Assets Non-Current | 9.07M |
| Goodwill and Intangible Assets | 8.18M |
| Liabilities Non-Current | 6.25M |
| Trade and Non-Trade Payables | 2.19M |
| Tax Liabilities | 423.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 40.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -887.00K |
| Net Cash Flow from Operations | -887.00K |